Domain > artielle.com

Welcome! Right click nodes and scroll the mouse to navigate the graph.

More information on this domain is in AlienVault OTX

DNS Resolutions

Date	IP Address
2025-01-07	155.130.138.26 (ClassC)

HTTP/1.1 200 OKServer: nginxDate: Mon, 09 Dec 2024 15:10:59 GMTContent-Type: text/htmlTransfer-Encoding: chunkedConnection: keep-aliveX-Powered-By: PHP/5.4.16Vary: Accept-Encoding,User-AgentX-Powered-

!DOCTYPE html PUBLIC -//W3C//DTD XHTML 1.0 Transitional//EN http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd>html xmlnshttp://www.w3.org/1999/xhtml>head>meta http-equivcontent-type contenttext/html; charsetUTF-8 />title>Artielle ImmunoTherapeutics | Home /title>style typetext/css>!---->/style>link hrefcss/main.css relstylesheet typetext/css />/head>body>!-- Header content begins -->div idtop-wrapper>!-- leftsidetp-->div classtop-lft hd-left idhd-left stylemargin-top:0px; >div >img srcimages/ArtielleLogo.png alt width176 height47 >/div>/div>!-- rightsidetp-->div idhd-right classhd-right stylemargin-top:0px;  > 	 div> em styletext-align:right >a hrefindex.php>Home/a> | a hrefcareers>Careers/a> | a hrefcontact>Contact/a>/em>br /> 	   ul>	   li>a hrefcompany/ title classblueb>Company/a>/li>        li>a hrefpipeline/ title classblueb>Pipeline/a>/li> 	   li>a hreftechnology/ title classblueb>Technology/a>/li>       li>a hrefnews-and-publications/>Publications/a>/li>	 /ul>    /div>/div>/div>!-- Header content ends -->!-- begin main body content -->div idbody-wrapper>div idmid-content>img srcimages/home-img.jpg width780 height230 />/div>div idbody-content>h1 styleborder-bottom:0px dotted #cacaca; color:#650065; >Artielle ImmunoTherapeutics/h1>p>Artielle Immunotherapeutics is a clinical stage, venture-backed company developing a novel, first-in-class platform of biologic drugs to treat a range of inflammatory and degenerative diseases.   /p>p>Artielle’s initial therapeutic focus is on neuroinflammatory and degenerative diseases including multiple sclerosis (MS), optic neuritis, methamphetamine addiction and stroke.  Additional applications are being pursued in other diseases including rheumatoid arthritis (RA), uveitis, age-related macular degeneration (AMD) and celiac disease./p>/div>!-- end main body content -->!-- Begin Footer Content -->div classfooter>div classfooter-copy>br />br> © 2011 Artielle ImmunoTherapeutics, Inc., All Rights Reserved. a hrefterms>Terms of Use/a> br>a hrefindex.php>Home/a> | a hr

View on OTX | View on ThreatMiner

Data with thanks to AlienVault OTX, VirusTotal, Malwr and others. [Sitemap]

Domain > artielle.com

Is this malicious?

DNS Resolutions

Port 80